Format

Send to

Choose Destination
JMIR Public Health Surveill. 2017 Dec 5;3(4):e85. doi: 10.2196/publichealth.8000.

HIV Surveillance Among Pregnant Women Attending Antenatal Clinics: Evolution and Current Direction.

Author information

1
Division of Global HIV and TB, US Centers for Disease Control and Prevention, Atlanta, GA, United States.
2
HIV Strategic Information and Planning, World Health Organization, Geneva, Switzerland.
3
Strategic Information and Monitoring Division, Joint United Nations Programme on HIV/AIDS, Geneva, Switzerland.
4
Office of the US Global AIDS Coordinator, Washington, DC, United States.

Abstract

Since the late 1980s, human immunodeficiency virus (HIV) sentinel serosurveillance among pregnant women attending select antenatal clinics (ANCs) based on unlinked anonymous testing (UAT) has provided invaluable information for tracking HIV prevalence and trends and informing global and national HIV models in most countries with generalized HIV epidemics. However, increased coverage of HIV testing, prevention of mother-to-child transmission (PMTCT), and antiretroviral therapy has heightened ethical concerns about UAT. PMTCT programs now routinely collect demographic and HIV testing information from the same pregnant women as serosurveillance and therefore present an alternative to UAT-based ANC serosurveillance. This paper reports on the evolution and current direction of the global approach to HIV surveillance among pregnant women attending ANCs, including the transition away from traditional UAT-based serosurveillance and toward new guidance from the World Health Organization and the Joint United Nations Programme on HIV/AIDS on the implementation of surveillance among pregnant women attending ANCs based on routine PMTCT program data.

KEYWORDS:

HIV; ethics; pregnant women; prenatal; surveillance

Supplemental Content

Full text links

Icon for JMIR Publications Icon for PubMed Central
Loading ...
Support Center